These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 5107010)

  • 1. Substrate binding site in bovine chymotrypsin A-gamma. A crystallographic study using peptide chloromethyl ketones as site-specific inhibitors.
    Segal DM; Powers JC; Cohen GH; Davies DR; Wilcox PE
    Biochemistry; 1971 Sep; 10(20):3728-38. PubMed ID: 5107010
    [No Abstract]   [Full Text] [Related]  

  • 2. The inhibition of chymotrypsin A4 with a homologous series of chloromethyl ketone reagents.
    Stevenson KJ; Smillie LB
    Can J Biochem; 1970 Mar; 48(3):364-75. PubMed ID: 5438324
    [No Abstract]   [Full Text] [Related]  

  • 3. Kinetics of the reaction of chymotrypsin A with peptide chloromethyl ketones in relation to its subsite specificity.
    Kurachi K; Powers JC; Wilcox PE
    Biochemistry; 1973 Feb; 12(4):771-7. PubMed ID: 4691518
    [No Abstract]   [Full Text] [Related]  

  • 4. A chemical and crystallographic study of carbamyl-chymotrypsin A.
    Robillard GT; Powers JC; Wilcox PE
    Biochemistry; 1972 May; 11(10):1773-84. PubMed ID: 5063532
    [No Abstract]   [Full Text] [Related]  

  • 5. The topographical differences in the active site region of alpha-chymotrypsin, subtilisin Novo, and subtilisin Carlsberg. Mapping the aromatic binding site by inhibitors (virtual substrates).
    Bosshard HR; Berger A
    Biochemistry; 1974 Jan; 13(2):266-77. PubMed ID: 4810052
    [No Abstract]   [Full Text] [Related]  

  • 6. An x-ray crystallographic study of the binding of peptide chloromethyl ketone inhibitors to subtilisin BPN'.
    Robertus JD; Alden RA; Birktoft JJ; Kraut J; Powers JC; Wilcox PE
    Biochemistry; 1972 Jun; 11(13):2439-49. PubMed ID: 5040650
    [No Abstract]   [Full Text] [Related]  

  • 7. A kinetic investigation of the crystallographically deduced binding subsites of bovine chymotrypsin A .
    Segal DM
    Biochemistry; 1972 Feb; 11(3):349-56. PubMed ID: 5062058
    [No Abstract]   [Full Text] [Related]  

  • 8. Preparation and kinetic properties of a new form of chymotrypsin which is active at alkaline pH: 1 -chymotrypsin.
    Valenzuela P; Bender ML
    J Biol Chem; 1973 Jul; 248(14):4909-14. PubMed ID: 4736884
    [No Abstract]   [Full Text] [Related]  

  • 9. The aromatic substrate binding site in subtilisin BPN' and its resemblance to chymotrypsin.
    Kraut J; Robertus JD; Birktoft JJ; Alden RA; Wilcox PE; Powers JC
    Cold Spring Harb Symp Quant Biol; 1972; 36():117-23. PubMed ID: 4508128
    [No Abstract]   [Full Text] [Related]  

  • 10. The study of alpha-chymotrypsin by x-ray diffraction. The Third CIBA Medal Lecture.
    Blow DM
    Biochem J; 1969 Apr; 112(3):261-8. PubMed ID: 5801300
    [No Abstract]   [Full Text] [Related]  

  • 11. Partial identification of a chymotrypsin formed by incubation of bovine chymotrypsinogen A with papain.
    Shaw MC; Gratecos D
    Biochim Biophys Acta; 1971 Apr; 235(1):188-90. PubMed ID: 5104454
    [No Abstract]   [Full Text] [Related]  

  • 12. Amino acids around an active center histidine in a turtle chymotrypsin.
    Möckel W; Barnard EA
    Biochim Biophys Acta; 1969 Dec; 194(2):622-4. PubMed ID: 5392096
    [No Abstract]   [Full Text] [Related]  

  • 13. Properties of the isoleucyl amino-terminus of alpha-chymotrypsin.
    Kaplan H
    Biochem Biophys Res Commun; 1971 Mar; 42(6):1042-9. PubMed ID: 5550795
    [No Abstract]   [Full Text] [Related]  

  • 14. Histidine sequences in the active centres of some 'serine' proteinases.
    Smillie LB; Hartley BS
    Biochem J; 1966 Oct; 101(1):232-41. PubMed ID: 5971785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human pancreatic enzymes: amino acid sequence of the A-chain of human chymotrypsin II.
    Travis J
    Biochem Biophys Res Commun; 1972 Sep; 48(5):1111-6. PubMed ID: 5066284
    [No Abstract]   [Full Text] [Related]  

  • 16. Crystal structure of delta-chymotrypsin bound to a peptidyl chloromethyl ketone inhibitor.
    Mac Sweeney A; Birrane G; Walsh MA; O'Connell T; Malthouse JP; Higgins TM
    Acta Crystallogr D Biol Crystallogr; 2000 Mar; 56(Pt 3):280-6. PubMed ID: 10713514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability in the tertiary structure of alpha-chymotrypsin at 2.8-A resolution.
    Tulinsky A; Vandlen RL; Morimoto CN; Mani NV; Wright LH
    Biochemistry; 1973 Oct; 12(21):4185-92. PubMed ID: 4745666
    [No Abstract]   [Full Text] [Related]  

  • 18. Subtilisin BPN': inactivation by chloromethyl ketone derivates of peptide substrates.
    Morihara K; Oka T
    Arch Biochem Biophys; 1970 Jun; 138(2):526-31. PubMed ID: 5433587
    [No Abstract]   [Full Text] [Related]  

  • 19. The inhibition of chymotrypsin A4 and B with chloromethyl ketone reagents.
    Stevenson KJ; Smillie LB
    Can J Biochem; 1968 Nov; 46(11):1357-70. PubMed ID: 5687069
    [No Abstract]   [Full Text] [Related]  

  • 20. The reactivity of His-57 in chymotrypsin to alkylation.
    Shaw E; Ruscica J
    Arch Biochem Biophys; 1971 Aug; 145(2):484-9. PubMed ID: 5132101
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.